Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection

NCT02933905 · clinicaltrials.gov ↗

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Macular Edema
Vitreomacular Interface
Anti-VEGF Treatment

Interventions

DRUG: Intravitreal Ranibizumab injection

Sponsor

Fundació Institut Germans Trias i Pujol